Back to results
US 12,005,153 B2Granted
Compositions and methods for treating wounds
AssigneeSamuel E. Lynch
InventorSamuel E. Lynch
Life of this patent
Estimating the term…
Abstract
An improvement to the effectiveness or “take” of skin grafts or tissue replacements used to treat wounds is provided. A therapeutic composition comprising recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB) and a porous biocompatible carrier is first applied to the wound surface, followed by applying a skin substitute or tissue replacements composition.
Claims38
A method of treating a skin wound, the method comprising:
- (1) treating the wound surface by applying a sterile therapeutic composition consisting essentially of recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB) optionally in a physiologic solution and a porous biocompatible carrier to the wound surface, wherein the porous biocompatible carrier is a collagen sponge or collagen wound dressing or a gelatin, and wherein the carrier provides a substrate for cell attachment and vascular ingrowth as the wound heals, and said applying delivers at least about 10 μg rhPDGF-BB per cm2 of treated wound surface area up to 100 μg rhPDGF-BB per cm2 treated wound surface area, optionally wherein prior to treating the wound surface the wound is debrided to remove necrotic or infected tissue;
- (2) optionally covering the wound with a dressing;
- (3) optionally using a treatment regimen of repeating steps (1) - (2) for 2 to 20 times at treatment intervals of three or more days;
- and
- (4) applying a skin-substitute composition to the treated wound and optionally covering the wound with a second dressing.
2 more elements
Dependencies are inferred from the claim text.